No one with HIV should die from tuberculosis

The Lancet

Volumn 386, Issue 10010, 2015, Pages e48-e50

  Furin, Jennifer ^a   Akugizibwe, Paula ^b   Ditiu, Lucica ^c   Gray, Glenda ^d   Palmero, Domingo ^e   Zaidi, Sarah ^f  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CLINTON HEALTH ACCESS INITIATIVE   (United States)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e HOSPITAL F J MUÑIZ   (Argentina)

^f NONE   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

BEDAQUILINE; DELAMANID; ISONIAZID; TUBERCULOSTATIC AGENT;

CD4 LYMPHOCYTE COUNT; DIAGNOSTIC PROCEDURE; EPIDEMIC; EXPERIMENTAL THERAPY; FINANCIAL MANAGEMENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN RIGHTS; INFECTION CONTROL; MORTALITY; NOTE; PATIENT REFERRAL; PRIORITY JOURNAL; SCALE UP; TREATMENT OUTCOME; TUBERCULOSIS; VIRUS LOAD; WORLD HEALTH ORGANIZATION; AIDS-RELATED OPPORTUNISTIC INFECTIONS; COINFECTION; INTERNATIONAL COOPERATION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTITUBERCULAR AGENTS; COINFECTION; HUMANS; INTERNATIONAL COOPERATION; TUBERCULOSIS;

EID: 84949487071     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)00319-0     Document Type: Note

References (31)

1. WHO Global tuberculosis report 2014 2014 World Health Organization Geneva
2. M Straetemans, P Glaziou, AL Bierrenbach, C Sismanidis, MJ van der Werf Assessing tuberculosis case fatality ratio: a meta-analysis PLoS One 6 2011 e20755
3. A Odone, S Amadasi, RG White, TC Cohen, AD Grant, MGJ Houben The impact of antiretroviral therapy on mortality in HIV positive people during tuberculosis treatment: a systematic review and meta-analysis PLoS One 9 2014 e112017
4. P Isaakidis, EC Casas, M Das, X Tseretopoulou, EE Ntzani, N Ford Treatment outcomes for HIV and MDR-TB co-infected adults and children: systematic review and meta-analysis Int J Tuberc Lung Dis 19 2015 969 978
5. AD Harries, R Zachariah, EL Corbett et al. The HIV-associated tuberculosis epidemic - when will we act? Lancet 375 2010 1906 1919
6. WHO Report of a joint WHO HIV/AIDS and TB Department meeting, 2008. Three I's meeting 2008 World Health Organization Geneva http://www.who.int/hiv/pub/meetingreports/WHO-3Is-meeting-report.pdf (accessed Aug 18, 2015).
7. S Gupta, T Abimbola, A Date et al. Cost-effectiveness of the Three I's for HIV/TB and ART to prevent TB among people living with HIV Int J Tuberc Lung Dis 18 2014 1159 1165
8. SM Hermans, B Castelnuovo, C Katabira et al. Integration of HIV and TB services results in improved TB treatment outcomes and earlier prioritized ART initiation in a large urban HIV clinic in Uganda J Acquir Immune Defic Syndr 60 2012 e29 e35
9. B Durovni, V Saraceni, LH Moulton et al. Effect of improved tuberculosis screening and isoniazid preventive therapy on incidence of tuberculosis and death in patients with HIV in clinics in Rio de Janeiro, Brazil: a stepped wedge, cluster-randomised trial Lancet Infect Dis 13 2013 852 858
10. Stop TB Partnership. The global plan to stop TB 2016-2020 http://www.stoptb.org/global/plan/plan2/ 2015 (accessed Sept 11, 2015).
11. G Theron, HE Jenkins, F Cobelens et al. Data for action: collection and use of local data to end tuberculosis Lancet 2015 published online Oct 26. http://dx.doi.org/10.1016/S0140-6736(15)00321-9
12. CM Yuen, F Amanullah, A Dharmadhikari et al. Turning off the tap: stopping tuberculosis transmission through active case-finding and prompt effective treatment Lancet 2015 published online Oct 26. http://dx.doi.org/10.1016/S0140-6736(15)00322-0
13. MX Rangaka, SC Cavalcante, BJ Marais et al. Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection Lancet 2015 published online Oct 26. http://dx.doi.org/10.1016/S0140-6736(15)00323-2
14. KF Ortblad, JA Salomon, T Bärnighausen, R Atun Stopping tuberculosis: a biosocial model for sustainable development Lancet 2015 published online Oct 26. http://dx.doi.org/10.1016/S0140-6736(15)00324-4
15. TR Frieden, PI Fujiwara, RM Washko, MA Hamburg Tuberculosis in New York City - turning the tide N Engl J Med 333 1995 229 233
16. NM Graham, N Galai, KE Nelson et al. Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease Arch Intern Med 156 1996 889 894
17. SC Cavalcante, B Durovni, GL Barnes et al. Community-randomized trial of enhanced DOTS for tuberculosis control in Rio de Janeiro, Brazil Int J Tuberc Lung Dis 14 2010 203 209
18. SD Lawn, R Wood, KM De Cock, K Kranzer, JJ Lewis, GJ Churchyard Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources Lancet Infect Dis 10 2010 489 498
19. INSIGHT START Study Group Initiation of antiretroviral therapy in early asymptomatic HIV infection N Engl J Med 373 2015 795 807
20. NR Gandhi, JR Andrews, JC Brust et al. Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting Int J Tuberc Lung Dis 16 2012 90 97
21. SS Abdool Karim, K Naidoo, A Grobler et al. Timing of initiation of antiretroviral drugs during tuberculosis therapy N Engl J Med 362 2010 697 706
22. AB Suthar, SD Lawn, J del Amo et al. Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis PLoS Med 9 2012 e1001270
23. D Havlir, M Kendall, P Ive et al. Timing of antiretroviral therapy for HIV-1 and tuberculosis N Engl J Med 365 2011 1482 1491
24. The TEMPRANO ANRS 12136 Study Group A trial of early antiretrovirals and isoniazid preventive therapy in Africa N Engl J Med 373 2015 808 822
25. Cohen M, Chen Y, McCauley M, et al. Final results of the HPTN 052 randomized controlled trial: antiretroviral therapy prevents HIV transmission. 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention; July 19-22, 2015. Program number MOAC0106LB, track C.
26. AH Van't Hoog, HK Meme, KF Laserson et al. Screening strategies for tuberculosis prevalence surveys: the value of chest radiography and symptoms PLoS One 7 2012 e38691
27. S Swindells, L Komarow, S Tripathy et al. Screening for pulmonary tuberculosis in HIV-infected individuals: AIDS Clinical Trials Group Protocol A5253 Int J Tuberc Lung Dis 17 2013 532 539
28. AV Ritchie, I Ushiro-Lumb, D Edmaga et al. SAMBA HIV semiquantitative test, a new point-of-care viral-load-monitoring assay for resource-limited settings J Clin Microbiol 52 2014 3377 3383
29. S Gupta, R Granich, A Date et al. Review of policy and status of implementation of collaborative HIV-TB activities in 23 high-burden countries Int J Tuberc Lung Dis 18 2014 1149 1158
30. Clinton Health Access Initiative Survey on barriers to TB-HIV integration in 14 high-burden countries 2014 Clinton Health Access Initiative Boston, MA
31. AI Zumla, SH Gillespie, M Hoelscher et al. New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects Lancet Infect Dis 14 2014 327 340